Halozyme Therapeutics (HALO) Gross Profit (2010 - 2026)
Halozyme Therapeutics (HALO) reported Gross Profit of $401.83 million for Q2 2026, up 43.8% from $279.36 million a year earlier and up 35.1% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Gross Profit (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Halozyme Therapeutics' Gross Profit came in at $1.37 billion, up 38.2% year-over-year; for FY2025, it was $1.17 billion, up 36.4% from FY2024.
- Gross Profit has increased for seven consecutive years, with a five-year compound annual growth rate of 39.1% (FY2020 to FY2025).
- By year, Gross Profit came in at $855.91 million in FY2024 (+34.4%), $636.89 million in FY2023 (+22.3%), $520.81 million in FY2022 (+43.9%) and $361.9 million in FY2021 (+61.4%).
- The Q2 2026 figure ranks as the highest quarterly Gross Profit in data going back to Q2 2010.
- Year over year, Gross Profit has now increased in each of the last 11 quarters, with growth averaging 39.9% over the last eight quarters.
- The high point for year-over-year Gross Profit in five years was Q4 2022 (growth of 73.3%); the low point was Q4 2021 (a decline of 15.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $297.47 million (Q1 2026), $373 million (Q4 2025) and $299.02 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Halozyme Therapeutics | 12.20 Bn | 10.80 Bn | 401.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 401.83 Mn |
| Mar 31, 2026 | 297.47 Mn |
| Dec 31, 2025 | 373.00 Mn |
| Sep 30, 2025 | 299.02 Mn |
| Jun 30, 2025 | 279.36 Mn |
| Mar 31, 2025 | 216.46 Mn |
| Dec 31, 2024 | 255.95 Mn |
| Sep 30, 2024 | 240.66 Mn |
| Jun 30, 2024 | 191.75 Mn |
| Mar 31, 2024 | 167.55 Mn |
| Dec 31, 2023 | 177.74 Mn |
| Sep 30, 2023 | 161.21 Mn |
| Jun 30, 2023 | 170.97 Mn |
| Mar 31, 2023 | 126.97 Mn |
| Dec 31, 2022 | 139.38 Mn |
| Sep 30, 2022 | 161.66 Mn |
| Jun 30, 2022 | 118.42 Mn |
| Mar 31, 2022 | 101.36 Mn |
| Dec 31, 2021 | 80.42 Mn |
| Sep 30, 2021 | 97.24 Mn |
API Access
Halozyme Therapeutics Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();